OR WAIT null SECS
December 12, 2022
PictorLabs, a digital pathology company developing an AI-powered virtual staining platform, formally announced its launch at the start of December.
December 03, 2022
Overall industry growth conceals growing numbers of smaller, faster-paced, adaptable corporate structures.
December 02, 2022
mRNA may not be a train we necessarily all need to get onboard immediately, but we should know where the central train station is located, and what it connects us to.
November 30, 2022
AstraZeneca inked a deal worth up to $320 million to purchase Neogene Therapeutics, a biotech start-up focused on T-cell receptor therapies.
November 28, 2022
Merck will purchase Imago BioSciences, a biotechnology company focused on bone marrow disorders, for approximately $1.35 billion.
November 22, 2022
The collaboration will see the companies develop investigational next-generation bispecific immunotherapies for cancer.
November 21, 2022
Biotech startup, Cradle, has raised $5.4 million in seed funding with an AI-enabled design platform that allows for the synthetic building of cell factories to produce proteins.
November 16, 2022
The deal will see Sanofi use Insilico’s AI drug discovery platform to advance up to six new drug development candidates.
Indivior’s acquisition of Opiant grants them access to the company’s portfolio of investigational opioid overdose reversal agent, OPNT003.
November 14, 2022
Salipro Biotech has entered into a collaboration and license agreement with Sanofi to advance discovery programs.